RecruitingNot ApplicableNCT06085950

Transcranial Ultrasonic Stimulation in Treatment-resistant Depression : an Open-label Pilot Trial

Transcranial Ultrasonic Stimulation in Treatment-resistant Depression: an Open-label Pilot Trial


Sponsor

Centre Hospitalier St Anne

Enrollment

32 participants

Start Date

May 9, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The primary objective of this study is to optimize the protocol for the TUS administration in patients with TRD while gaining an initial impression of treatment efficacy.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Transcranial Ultrasonic Stimulation prototype for people with treatment resistant depression. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscranial Ultrasonic Stimulation prototype

Transcranial Ultrasonic Stimulation prototype delivers personalized low-intensity ultrasound stimulation


Locations(1)

GHU Sainte-Anne

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06085950


Related Trials